-+ 0.00%
-+ 0.00%
-+ 0.00%

HCW BIOLOGICS ENTERED AN EXCLUSIVE DISTRIBUTION AGREEMENT WITH AKRON BIOTECH TO COMMERCIALIZE HCW11-006 AS REAGENT USED TO SUPPORT PRODUCTION OF HIGHLY FUNCTIONAL HUMAN CAR-T CELLS

Reuters·09/08/2026 12:50:00

Please log in to view news